Autoantibodies to the N-methyl-d-aspartate receptor (NMDAR). NMDAR antibodies were first reported in young female patients with ovarian tumours and prominent psychiatric symptoms, amnesia, seizures etc. The antibodies are now also reported in males or females with no known tumour.
Tube
Serum Gel
ID
12821
Additional Information
The presence of these antibodies suggests an immunotherapy-responsive condition. For further information please refer to: Dalmau et al. Lancet Neurol. 2008 Dec; 7 (12): 1091 to 1098.
Turn Around
Refer to the relevant laboratory for up to date turn around times, allowing an additional 10 working days for samples processing, dispatch and reporting and validation of the results (estimated 28 days).
Send to
Samples should be sent to the department of Clinical Immunology at LGI who will refer to appropriate referral lab (Sheffield PRU).
Collection Con
No restrictions.
Frequency
Referred to external laboratory.
Sample REQ
Serum.
Ref. Range (Male)
NA Interpretive.
Ref. Range (Female)
NA Interpretive.
Ref. Range (Paed)
NA Interpretive.
Ref. Range Notes
Positive/Negative
Units
NA
IP Acute TAT
Contact referral laboratory. Contact Immunology at LGI if sample is to be sent urgently.
IP Routine TAT
Refer to relevant laboratory for up to date turn around times, allowing an additional 10 working days for samples processing, dispatch and reporting and validation of the results.
GP Acute TAT
Contact referral laboratory. Contact Immunology at LGI if sample is to be sent urgently.
GP Routine TAT
Refer to relevant laboratory for up to date turn around times, allowing an additional 10 working days for samples processing, dispatch and reporting and validation of the results.